PR Newswire BiotechOriginal article
Aqua Medical Treats First U.S. Patient for Type 2 Diabetes at UNC Health Using Investigational Through-The-Scope Endoscopic Therapy
Trial StartEndoscopic Metabolic RestorationPositive
AI Analysis
Summary
Aqua Medical announced successful treatment of the first U.S. patient in an FDA-authorized clinical trial evaluating an investigational through-the-scope endoscopic therapy for Type 2 Diabetes at UNC Health.
Clinical Trial Data
Patients
1
Outcome Details
First U.S. patient treated in FDA-authorized investigational through-the-scope endoscopic therapy
Importance:4/10
Sentiment:
0.60
type 2 diabetesendoscopic therapyclinical trialFDA authorizedmedical device
Read the original article
Published by PR Newswire Biotech on July 28, 2026 4:05 PM